Avant Genomics

Summary active Updated May 16, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Charlottesville, Virginia
Founded 2023
Latest Stage Seed
Total Raised $3M+

Founders

Rachelle Turiello Co-Founder & CEO
Renna Nouwairi Co-Founder & COO

About

Avant Genomics is a Charlottesville, Virginia-based biotech spun out of the University of Virginia by Rachelle Turiello (CEO) and Renna Nouwairi (COO) that is developing a fully automated platform for liquid biopsy sample preparation in precision cancer detection 123. The company’s Avant Source platform reduces sample preparation from over 50 manual steps to two steps, cuts processing time in half, and improves DNA yield by up to 70% compared to semi-automated tools — addressing a key bottleneck that currently limits clinical adoption of liquid biopsy 12. On May 13, 2026, Avant Genomics announced more than $3M in funding from TitletownTech, Halyard Ventures, Virginia Venture Partners, CAV Angels, and Global Impact Fund, with proceeds supporting R&D, manufacturing, and hiring 123.

Funding History

Date Round Amount Lead Co-investors
2026-05-13 Seed $3M+ TitletownTech Halyard Ventures, Virginia Venture Partners, CAV Angels, Global Impact Fund 123

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

No independently sourced founder quotes found at this time.

Sources


  1. Business Wire, “Avant Genomics Secures $3M+ in Funding to Accelerate First-in-kind Automated Platform for Liquid Biopsy Sample Preparation,” May 13, 2026. Accessed May 2026. https://www.businesswire.com/news/home/20260513888705/en/Avant-Genomics-Secures-$3M-in-Funding-to-Accelerate-First-in-kind-Automated-Platform-for-Liquid-Biopsy-Sample-Preparation

  2. GenomeWeb, “Avant Genomics Raises $3M to Develop Automated Liquid Biopsy Sample Prep Platform,” May 2026. Accessed May 2026. https://www.genomeweb.com/cancer/avant-genomics-raises-3m-develop-automated-liquid-biopsy-sample-prep-platform

  3. Clinical Lab Products, “Avant Genomics Raises $3M for Automated Liquid Biopsy Sample Preparation,” May 2026. Accessed May 2026. https://clpmag.com/disease-states/cancer/avant-genomics-raises-3m-for-automated-liquid-biopsy-preparation/